Could Self-Hypnosis ease migraine pain? new study investigates
NCT ID NCT07644299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an 8-session self-hypnosis program, delivered online in groups, can help adults with migraines reduce disability and improve well-being. Forty participants are randomly assigned to either the hypnosis training or a waitlist. The program teaches self-hypnosis exercises targeting pain, stress, and anxiety, with audio recordings for home practice. Researchers track changes in migraine impact, mood, and quality of life over several months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Self-hypnosis training (HYlaMI program)
What this could lead to
If effective, this could offer a drug-free option to help people with migraines manage pain, stress, and disability.
What could go wrong
This is a small early-stage study with only 40 participants, so results may not apply widely. The program requires time and commitment, and not everyone may benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR)
Montreal, Quebec, H1T 2M4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••